Glioblastoma Multiforme (GBM) remains one of the most aggressive and lethal forms of brain cancer. Despite advances in neurosurgery and oncology, treating this malignant tumor remains a major clinical challenge. However, recent breakthroughs in targeted therapy and immunotherapy are slowly